Li Z, Martens YA, Ren Y, et al. APOE genotype determines cell-type-specific pathological landscape of Alzheimer's disease. Neuron. 2025;113(9):1380-1397.e7.
Liu CC, Wang N, Chen Y, et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease. Nat Immunol. 2023;24(11):1854-1866.
Zhao J, Ikezu TC, Lu W, et al. APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids. Stem Cell Res Ther. 2023;14(1):214.
Qiao W, Chen Y, Zhong J, et al. Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology. Mol Neurodegener. 2023;18(1):8. Published 2023 Jan 31.
Meneses AD, Koga S, Li Z, et al. APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology. Ann Neurol. 2023;93(4):830-843.
Wang N, Wang M, Jeevaratnam S, et al. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol Neurodegener. 2022;17(1):75. Published 2022 Nov 23.
Zhao N, Qiao W, Li F, et al. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med. 2022;219(12):e20212479.
Chen K, Martens YA, Meneses A, et al. LRP1 is a neuronal receptor for α-synuclein uptake and spread. Mol Neurodegener. 2022;17(1):57.
Liu CC, Zhao J, Fu Y, et al. Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25(8):1020-1033.
Li Z, Heckman MG, Kanekiyo T, et al. Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology. 2022;98(20):e2036-e2045.
Liu CC, Murray ME, Li X, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13(613):eabc9375.
Zhao J, Lu W, Ren Y, et al. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids. Acta Neuropathol. 2021;142(5):807-825.
Yamazaki Y, Liu CC, Yamazaki A, et al. Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function. Neuron. 2021;109(3):438-447.e6.
Zhao J, Fu Y, Yamazaki Y, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11(1):5540.
Shinohara M, Kanekiyo T, Tachibana M, et al. APOE2 is associated with longevity independent of Alzheimer's disease. Elife. 2020;9:e62199.
Raulin AC, Martens YA, Bu G. Lipoproteins in the Central Nervous System: From Biology to Pathobiology. Annu Rev Biochem. 2022;91:731-759.
Martens YA, Zhao N, Liu CC, et al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias. Neuron. 2022;110(8):1304-1317.
Li Z, Shue F, Zhao N, Shinohara M, Bu G. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. Mol Neurodegener. 2020;15(1):63.
